PureTech research reveals gaps in IPF patient care
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PureTech Health PLC (PRTC)
PureTech Health PLC stock price live, this page displays LON PRTC stock exchange data. View the PRTC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the PureTech Health PLC real time stock price chart below.
What Is the PureTech Health PLC Stock Price Today?
The PureTech Health PLC stock price today is 122.79.
What Is the Stock Symbol for PureTech Health PLC?
The stock symbol for PureTech Health PLC is "PRTC."
What Stock Exchange Does PureTech Health PLC Trade On?
PureTech Health PLC is listed and trades on the London stock exchange.
Is PureTech Health PLC a Good Stock to Buy?
Determining whether PureTech Health PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRTC quote. (ISIN: GB00BY2Z0H74)
What Is the PureTech Health PLC Stock Price Today?
The PureTech Health PLC stock price today is 122.79.
What Is the Stock Symbol for PureTech Health PLC?
The stock symbol for PureTech Health PLC is "PRTC."
What Stock Exchange Does PureTech Health PLC Trade On?
PureTech Health PLC is listed and trades on the London stock exchange.
Is PureTech Health PLC a Good Stock to Buy?
Determining whether PureTech Health PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRTC quote. (ISIN: GB00BY2Z0H74)
London
Currency in GBP
122.79
-0.60(-0.49%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
122.40
125.18
52 wk Range
100.40
238.50
PRTC Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
PRTC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
122.40125.18
52 wk Range
100.40238.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PRTC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
473.64
Upside
+285.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
- PureTech receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- PureTech research reveals gaps in IPF patient care
- Investing.com
- PureTech receives Investment Bank Analyst Rating Update
- Investing.com
Pro
PureTech Health PLC Company Profile
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. The company also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development; oral therapies based on defined bacterial consortia that is in phase 3 clinical stage; and engineering hematopoietic stem cells to enable targeted therapies for patients with blood cancers. Further, it develops voice-based technology platform that detects changes in the sound of voice that are linked with health conditions, including depression, anxiety, and respiratory disease. The company was incorporated in 2015 and is based in Boston, Massachusetts.
Compare PRTC to Peers and Sector
Metrics to compare | PRTC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPRTCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 7.3x | −0.6x | −0.5x | |
PEG Ratio | 0.04 | 0.00 | 0.00 | |
Price/Book | 0.9x | 3.4x | 2.6x | |
Price / LTM Sales | 80.8x | 10.4x | 2.9x | |
Upside (Analyst Target) | 291.6% | 336.4% | 53.0% | |
Fair Value Upside | Unlock | 3.5% | 8.9% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 473.64
(+285.73% Upside)
Earnings
Latest Release
Aug 28, 2024
EPS / Forecast
-0.15 / --
Revenue / Forecast
288.00K / --
People Also Watch
FAQ
What Is the PureTech Health (PRTC) Stock Price Today?
The PureTech Health stock price today is 122.79
What Stock Exchange Does PureTech Health Trade On?
PureTech Health is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for PureTech Health?
The stock symbol for PureTech Health is "PRTC."
What Is the PureTech Health Market Cap?
As of today, PureTech Health market cap is 294.93M.
What Is PureTech Health's Earnings Per Share (TTM)?
The PureTech Health EPS (TTM) is 0.21.
From a Technical Analysis Perspective, Is PRTC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.